🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objectives * Primary: To evaluate the safety and tolerability of FG-3019 i...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2008-12
Trial ID
NCT01181245
Treatments Being Tested
This is a Phase 2, open-label, single arm trial of pamrevlumab (FG-3019) to...
Status
Terminated
Location
David Geffen School of Medicine at UCLA
Start Date
2016-01-04
Trial ID
NCT02606136
Treatments Being Tested
This is a Phase 3 trial to evaluate the efficacy and safety of 30 milligram...
Status
Terminated
Location
University of Alabama at Birmingham Hospital
Start Date
2019-06-18
Trial ID
NCT03955146
Treatments Being Tested
To evaluate the efficacy and safety of pamrevlumab versus placebo in combin...
Status
Terminated
Location
Arkansas Children's
Start Date
2020-08-10
Trial ID
NCT04371666
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of FG-...
Status
Terminated
Location
Multiple Locations
Start Date
2008-04
Trial ID
NCT00782561
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of two...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00754143
This is a randomized, open-label, parallel-arm study to investigate the eff...
Status
Completed
Location
Fondazione Policlinico Agostino Gemelli IRCCS
Start Date
2020-05-12
Trial ID
NCT05262309
Treatments Being Tested
This study evaluates the efficacy and safety of intravenous (IV) infusions ...
Status
Terminated
Location
Research Center
Start Date
2020-06-20
Trial ID
NCT04432298
Treatments Being Tested
To evaluate the efficacy and safety of pamrevlumab versus placebo in combin...
Status
Terminated
Location
Arkansas Children's Hospital
Start Date
2021-03-03
Trial ID
NCT04632940
Treatments Being Tested
This is a Phase 3 trial to evaluate the efficacy and safety of 30 milligram...
Status
Terminated
Location
UAB Lung Health Center
Start Date
2020-09-30
Trial ID
NCT04419558
Treatments Being Tested